Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review

BACKGROUND: Coronavirus disease 2019 (COVID-19) has affected >210 million people worldwide. An optimal therapeutic approach for COVID-19 remains uncertain, to date. Since the history of cancer was linked to higher mortality rates due to COVID-19, the establishment of a safe and effective vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Corti, C., Antonarelli, G., Scotté, F., Spano, J.P., Barrière, J., Michot, J.M., André, F., Curigliano, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552625/
https://www.ncbi.nlm.nih.gov/pubmed/34718117
http://dx.doi.org/10.1016/j.annonc.2021.10.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552625/
https://www.ncbi.nlm.nih.gov/pubmed/34718117
http://dx.doi.org/10.1016/j.annonc.2021.10.014

Ejemplares similares